Oral warfarin affects some aspects of systemic immunomodulation with topical dinitrochlorobenzene (DNCB) in rats

References

• Holzer AM, Kaplan LL, Levis WR. Haptens as drugs: contact allergens are powerful topical immunomodulators. J Drugs Dermatol 2006;5:410–416
   PubMedGoogle Scholar
• Happle R. The potential hazards of dinitrochlorobenzene. Arch Dermatol 1985;121:330–332
   PubMedGoogle Scholar
• Mohan KH, Balachandran C, Shenoi SD, et al. Topical dinitrochlorobenzene (DNCB) for alopecia areata: revisited. Indian J Dermatol Venereol Leprol 2008;74:401–402
   PubMed Web of Science ®Google Scholar
• Herrmann G, Groth W, Krieg T, Mauch C. Complete remission of Merkel cell carcinoma of the scalp with local and regional metastases after topical treatment with dinitrochlorbenzol. J Am Acad Dermatol 2004;50:965–969
   PubMed Web of Science ®Google Scholar
• von Nida J, Quirk C. Successful treatment of in-transit melanoma metastases using topical 2–4 dinitrochlorobenzene. Australas J Dermatol 2003;44:277–280
   PubMedGoogle Scholar
• Stricker RB, Zhu YS, Elswood BF, et al. Pilot study of topical dinitrochlorobenzene (DNCB) in human immunodeficiency virus infection. Immunol Lett 1993;36:1–6
   PubMed Web of Science ®Google Scholar
• Stricker RB, Goldberg B, Mills LB, Epstein WL. Decrease in viral load associated with topical dinitrochlorobenzene therapy in HIV disease. Res Virol 1997;148:343–348
   PubMedGoogle Scholar
• Traub A, Margulis SB, Stricker RB. Topical immune modulation with dinitrochlorobenzene in HIV disease: a controlled trial from Brazil. Dermatology (Basel) 1997;195:369–373
   PubMed Web of Science ®Google Scholar
• Stricker RB, Goldberg B, Epstein WL. Immunological changes in patient with systemic lupus erythematosus treated with topical dinitrochlorobenzene. Lancet 1995;345:1505–1506
   PubMed Web of Science ®Google Scholar
• Yoshizawa Y, Matsui H, Izaki S, et al. Topical dinitrochlorobenzene therapy in the treatment of refractory atopic dermatitis: systemic immunotherapy. J Am Acad Dermatol 2000;42:258–262
   PubMed Web of Science ®Google Scholar
• Yoshizawa Y, Izaki S, Kitamura K, Kawana S. Systemic immunotherapy with topical dinitrochlorobenzene as additional treatment of alopecia areata. Acta Derm Venereol 2002;82:136–138
   PubMed Web of Science ®Google Scholar
• Belij S, Popov A, Zolotarevski L, et al. Systemic immunomodulatory effects of topical dinitrochlorobenzene (DNCB) in rats. Activity of peripheral blood polymorphonuclear cells. Environ Toxicol Pharmacol 2012;33:168–180
   PubMed Web of Science ®Google Scholar
• Tran LS, Bergot AS, Mattarollo SR, et al. Human papillomavirus e7 oncoprotein transgenic skin develops an enhanced inflammatory response to 2,4-dinitrochlorobenzene by an arginase-1-dependent mechanism. J Invest Dermatol 2014;134:2438–2446
   PubMed Web of Science ®Google Scholar
• Pirmohamed M. Warfarin: almost 60 years old and still causing problems. Br J Clin Pharmacol 2006;62:509–511
   PubMed Web of Science ®Google Scholar
• Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004;329:15–19
   PubMed Web of Science ®Google Scholar
• Linkins LA, Weitz JI. New anticoagulants. Semin Thromb Hemost 2003;29:619–631
   PubMed Web of Science ®Google Scholar
• Gallerani M, Manfredini R, Moratelli S. Non-haemorrhagic adverse reactions of oral anticoagulant therapy. Int J Cardiol 1995;49:1–7
   PubMed Web of Science ®Google Scholar
• Berkarda B, Bouffard-Eyüboglu H, Derman U. The effect of coumarin derivatives on the immunological system of man. Agents Actions 1983;13:50–52
   PubMedGoogle Scholar
• Bobek V, Boubelik M, Fiserová A, et al. Anticoagulant drugs increase natural killer cell activity in lung cancer. Lung Cancer 2005;47:215–223
   PubMed Web of Science ®Google Scholar
• Bobek V, Kovarik J. Antitumor and antimetastatic effect of warfarin and heparins. Biomed Pharmacother 2004;58:213–219
   PubMed Web of Science ®Google Scholar
• Nakchbandi W, Müller H, Singer MV, et al. Effects of low-dose warfarin and regional chemotherapy on survival in patients with pancreatic carcinoma. Scand J Gastroenterol 2006;41:1095–1104
   PubMed Web of Science ®Google Scholar
• Goudarzipour K, Ghazizadeh F, Hoseini Tavassol H, Behnam B. Warfarin-induced eosinophilia in a child with Burkitt lymphoma: a case report. Iran J Pharm Res 2015;14:887–890
   PubMed Web of Science ®Google Scholar
• Hall D, Link K. Eosinophilia associated with Coumadin. N Engl J Med 1981;304:732–733
   PubMed Web of Science ®Google Scholar
• Jo YM, Park TH, Jeong IH, et al. Warfarin-induced eosinophilic pleural effusion. Korean Circ J 2011;41:109–112
   PubMed Web of Science ®Google Scholar
• Teragaki M, Kawano H, Makino R, et al. A case of warfarin-induced eosinophilia. Intern Med 2012;51:1627–1629
   PubMed Web of Science ®Google Scholar
• Ad-El DD, Meirovitz A, Weinberg A, et al. Warfarin skin necrosis: local and systemic factors. Br J Plast Surg 2000;53:624–626
   PubMedGoogle Scholar
• Hermes B, Haas N, Henz BM. Immunopathological events of adverse cutaneous reactions to coumarin and heparin. Acta Derm Venereol 1997;77:35–38
   PubMed Web of Science ®Google Scholar
• Kapoor KG, Bekaii-Saab T. Warfarin-induced allergic interstitial nephritis and leucocytoclastic vasculitis. Intern Med J 2008;38:281–283
   PubMed Web of Science ®Google Scholar
• Kuwahara T, Hamada M, Inoue Y, et al. Warfarin-induced eosinophilic pleurisy. Intern Med 1995;34:794–796
   PubMed Web of Science ®Google Scholar
• Belij S, Miljković D, Popov A, et al. Effects of subacute oral warfarin administration on peripheral blood granulocytes in rats. Food Chem Toxicol 2012;50:1499–1507
   PubMed Web of Science ®Google Scholar
• Edwards RL, Rickles FR. Delayed hypersensitivity in man: effects of systemic anticoagulation. Science 1978;200:541–543
   PubMed Web of Science ®Google Scholar
• Kurohara M, Yasuda H, Moriyama H, et al Low-dose warfarin functions as an immunomodulator to prevent cyclophosphamide-induced NOD diabetes. Kobe J Med Sci 2008;54:E1–E13
   PubMedGoogle Scholar
• Popov A, Mirkov I, Miljković D, et al. Contact allergic response to dinitrochlorobenzene (DNCB) in rats: insight from sensitization phase. Immunobiology 2011;216:763–770
   PubMed Web of Science ®Google Scholar
• Popov Aleksandrov A, Mirkov I, Demenesku J, et al. Strain differences in contact hypersensitivity reaction to dinitrochlorobenzene (DNCB) in rats. Food Chem Toxicol 2015;75:94–103
   PubMed Web of Science ®Google Scholar
• Oez S, Platzer E, Welte K. A quantitative colorimetric method to evaluate the functional state of human polymorphonuclear leukocytes. Blut 1990;60:97–102
   PubMedGoogle Scholar
• Denizot F, Lang L. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986;89:271–277
   PubMed Web of Science ®Google Scholar
• Bozeman PM, Learn DB, Thomas EL. Assay of the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase. J Immunol Methods 1990;126:125–133
   PubMed Web of Science ®Google Scholar
• Choi HS, Kim JW, Cha YN, Kim C. A quantitative nitroblue tetrazolium assay for determining intracellular superoxide anion production in phagocytic cells. J Immunoassay Immunochem 2006;27:31–39
   PubMed Web of Science ®Google Scholar
• Hibbs JB Jr, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988;157:87–94
   PubMed Web of Science ®Google Scholar
• Hirsh J, Dalen JE, Anderson DR, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1998;114:445S–469S
   PubMed Web of Science ®Google Scholar
• Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. Faseb J 2008;22:659–661
   PubMed Web of Science ®Google Scholar
• Kuebler WM. Inflammatory pathways and microvascular responses in the lung. Pharmacol Rep 2005;57:196–205
   PubMed Web of Science ®Google Scholar
• Kuebler WM, Goetz AE. The marginated pool. Eur Surg Res 2002;34:92–100
   PubMed Web of Science ®Google Scholar
• Edwards RL, Schreiber E, Brande W. The effect of sodium warfarin on rabbit monocyte tissue factor expression. Thromb Res 1986;42:125–137
   PubMed Web of Science ®Google Scholar
• Klebanoff SJ, Vadas MA, Harlan JM, et al. Stimulation of neutrophils by tumor necrosis factor. J Immunol 1986;136:4220–4225
   PubMed Web of Science ®Google Scholar
• Berkow RL, Dodson MR. Biochemical mechanisms involved in the priming of neutrophils by tumor necrosis factor. J Leukoc Biol 1988;44:345–352
   PubMed Web of Science ®Google Scholar
• Oez S, Welte K, Platzer E, Kalden JR. A simple assay for quantifying the inducible adherence of neutrophils. Immunobiology 1990;180:308–315
   PubMed Web of Science ®Google Scholar
• Kharazmi A, Nielsen H, Rechnitzer C, Bendtzen K. Interleukin 6 primes human neutrophil and monocyte oxidative burst response. Immunol Lett 1989;21:177–184
   PubMed Web of Science ®Google Scholar
• Biffl WL, Moore EE, Moore FA, et al. Interleukin-6 potentiates neutrophil priming with platelet-activating factor. Arch Surg 1994;129:1131–1136
   PubMedGoogle Scholar
• Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 2006;6:173–182
   PubMed Web of Science ®Google Scholar